NYSE:HUM
NYSE:HUMHealthcare

Is Humana (HUM) Pricing Looked At Again After Recent Share Price Rebound

If you are wondering whether Humana’s current share price fairly reflects its long term prospects, you are not alone. This article is designed to help you think through that question clearly. Humana’s stock most recently closed at US$276.85, with returns of 4.7% over the last week, 7.9% over the last month, 4.7% year to date, 4.3% over the last year, and longer term returns of a 41.8% decline over three years and a 28.8% decline over five years. Recent attention on Humana has centered on how...
NYSE:BXMT
NYSE:BXMTMortgage REITs

A Look At Blackstone Mortgage Trust’s Valuation After Mixed Short And Long Term Returns

Blackstone Mortgage Trust (BXMT) is drawing fresh attention as investors reassess the stock after a period of mixed short term returns, including a decline over the past month alongside a positive move over the past three months. See our latest analysis for Blackstone Mortgage Trust. At a share price of $19.45, Blackstone Mortgage Trust has seen a 4.42% 1 month share price decline. However, a 90 day share price return of 8.30% alongside a 1 year total shareholder return of 25.03% suggests...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

A Look At Regency Centers (REG) Valuation After Recent Share Price Pullback

Regency Centers (REG) has drawn fresh attention after recently closing at US$69.72, with short term returns mixed over the past week, month, and 3 months. This has prompted a closer look at its underlying fundamentals. See our latest analysis for Regency Centers. The recent pullback, with a 1 day share price return of a 1.27% decline from US$69.72, sits against a year to date share price return of 2.59% and a 1 year total shareholder return of 5.47%. This suggests momentum has been steady...
NasdaqGS:HURC
NasdaqGS:HURCMachinery

Hurco Companies (HURC) Quarterly Losses Reinforce Bearish Narratives Despite Low Sales Multiple

Hurco Companies (HURC) closed FY 2025 with fourth quarter revenue of US$45.5 million and a basic EPS loss of US$0.48, while trailing twelve month revenue stood at US$178.6 million against a basic EPS loss of US$2.34. Over recent periods, the company has seen quarterly revenue move between US$40.9 million and US$53.7 million, with basic EPS losses ranging from US$0.22 to US$1.47. This sets a clear backdrop of pressure on profitability that keeps margins front and center for investors assessing...
NasdaqGS:LENZ
NasdaqGS:LENZPharmaceuticals

A Look At LENZ Therapeutics (LENZ) Valuation After New Middle East VIZZ Distribution Agreement

LENZ Therapeutics (LENZ) shares are in focus after the company signed an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO to register and commercialize its VIZZ eye drop for presbyopia across multiple Middle Eastern markets. See our latest analysis for LENZ Therapeutics. The distribution deal comes after a weak run for the stock, with a 30 day share price return of 40.62% and a 90 day share price return of 61.67%, while the 1 year total shareholder return sits at...
NYSE:CRGY
NYSE:CRGYOil and Gas

Assessing Crescent Energy (CRGY) Valuation After Recent Share Price Weakness

Crescent Energy (CRGY) has been drawing attention after a mixed return profile, with the share price down about 17% over the past month but remaining roughly flat over the past 3 months and weaker over the past year. See our latest analysis for Crescent Energy. At the latest share price of $8.12, Crescent Energy’s recent performance has been weak, with a 7 day share price return of 4.6% decline and a 1 year total shareholder return of 46.2% decline, suggesting momentum has been fading rather...
NYSE:JBTM
NYSE:JBTMMachinery

Is JBT Marel (JBTM) Still Attractive After Recent Share Price Strength?

If you are wondering whether JBT Marel at US$156.04 is still a sensible entry point or more of a hold, the next sections will walk through what the current price may be implying about value. The stock has recorded returns of 3.6% over the past week, 1.5% over the last month, 3.6% year to date and 28.5% over the past year, with a 55.0% return over three years and 25.8% over five years. These figures can affect how investors think about both upside potential and downside risk. Recent attention...
NYSE:RVTY
NYSE:RVTYLife Sciences

Assessing Revvity’s (RVTY) Valuation After New AI Partnership With Eli Lilly

What Lilly’s AI tie-up could mean for Revvity stock Revvity (RVTY) just announced a collaboration with Eli Lilly that puts Lilly’s TuneLab AI and machine learning models inside the Revvity Signals platform, directly tying the stock story to AI-enabled drug discovery workflows. The move builds on Revvity’s Signals Xynthetica and Models-as-a-Service offerings. It gives biotech customers a way to apply Lilly’s predictive models to their own data while keeping proprietary information protected...
NYSE:BRO
NYSE:BROInsurance

Is Brown & Brown (BRO) Pricing Make Sense After 20% One Year Share Price Decline?

Wondering whether Brown & Brown at around US$80.64 is offering fair value right now, or if the market is mispricing it? This article walks through that question in plain English. The stock is up 3.9% over the last week and 4.0% over the last month, but that comes after a 20.4% decline over the past year, even with 3 year and 5 year returns of 34.2% and 80.1% respectively. These moves have kept Brown & Brown on many investors' radars, as they reassess what the recent share price says about...
NYSE:GBTG
NYSE:GBTGHospitality

Assessing Global Business Travel Group’s (GBTG) Valuation After New Rail Partnership Opens Sustainability-Focused Growth Avenues

Shares of Global Business Travel Group (GBTG) moved after parent investor Certares partnered with Italian rail operator FS to promote high speed rail over short haul flights, a development tied closely to rising sustainability priorities. See our latest analysis for Global Business Travel Group. The sustainability focused rail partnership arrives at a time when GBTG’s share price, last closing at US$8.15, has a 7 day share price return of 8.38% and a 90 day share price return of 8.09%. The 3...
NYSE:TPH
NYSE:TPHConsumer Durables

Citizens Coverage And Cheaper Mortgages Refocus Attention On Tri Pointe Homes (TPH) Valuation

Citizens coverage and mortgage rate shift move Tri Pointe Homes Tri Pointe Homes (TPH) gained 5.4% in morning trading after Citizens initiated coverage with a "Market Outperform" rating, coinciding with two year fixed mortgage rates slipping below 4% for the first time since August 2022. See our latest analysis for Tri Pointe Homes. The strong 1 day share price return of 8.68% and 7 day return of 12.20% build on a 90 day share price return of 14.18%, while the 3 year total shareholder return...